BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32145401)

  • 1. TGF-β in radiotherapy: Mechanisms of tumor resistance and normal tissues injury.
    Farhood B; Khodamoradi E; Hoseini-Ghahfarokhi M; Motevaseli E; Mirtavoos-Mahyari H; Eleojo Musa A; Najafi M
    Pharmacol Res; 2020 May; 155():104745. PubMed ID: 32145401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta signaling in cancer radiotherapy.
    Wang J; Xu Z; Wang Z; Du G; Lun L
    Cytokine; 2021 Dec; 148():155709. PubMed ID: 34597918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation.
    Rube CE; Uthe D; Schmid KW; Richter KD; Wessel J; Schuck A; Willich N; Rube C
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1033-42. PubMed ID: 10863076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment.
    Chung JY; Chan MK; Li JS; Chan AS; Tang PC; Leung KT; To KF; Lan HY; Tang PM
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression.
    Yang L; Pang Y; Moses HL
    Trends Immunol; 2010 Jun; 31(6):220-7. PubMed ID: 20538542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated Macrophages (TAMs) in Cancer Resistance; Modulation by Natural Products.
    Lafta HA; AbdulHussein AH; Al-Shalah SAJ; Alnassar YS; Mohammed NM; Akram SM; Qasim MT; Najafi M
    Curr Top Med Chem; 2023; 23(12):1104-1122. PubMed ID: 36722486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interactions and communications in tumor resistance to radiotherapy: Therapy perspectives.
    Ashrafizadeh M; Farhood B; Eleojo Musa A; Taeb S; Najafi M
    Int Immunopharmacol; 2020 Oct; 87():106807. PubMed ID: 32683299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β and Cancer Immunotherapy.
    MaruYama T; Chen W; Shibata H
    Biol Pharm Bull; 2022; 45(2):155-161. PubMed ID: 35110501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta in cancer and metastasis.
    Jakowlew SB
    Cancer Metastasis Rev; 2006 Sep; 25(3):435-57. PubMed ID: 16951986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells.
    Zhang Q; Jang TL; Yang X; Park I; Meyer RE; Kundu S; Pins M; Javonovic B; Kuzel T; Kim SJ; Van Parijs L; Smith N; Wong L; Greenberg NM; Guo Y; Lee C
    Prostate; 2006 Feb; 66(3):235-47. PubMed ID: 16173028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionizing Radiation Promotes Epithelial-to-Mesenchymal Transition in Lung Epithelial Cells by TGF-β-producing M2 Macrophages.
    Park HR; Jo SK; Jung U
    In Vivo; 2019; 33(6):1773-1784. PubMed ID: 31662502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer.
    Pardali K; Moustakas A
    Biochim Biophys Acta; 2007 Jan; 1775(1):21-62. PubMed ID: 16904831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAMBI regulates macrophages inducing the differentiation of Treg through the TGF-β pathway in chronic obstructive pulmonary disease.
    Sun SW; Chen L; Zhou M; Wu JH; Meng ZJ; Han HL; Miao SY; Zhu CC; Xiong XZ
    Respir Res; 2019 Feb; 20(1):26. PubMed ID: 30728014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Fas ligand and transforming growth factor beta in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy.
    Kim R; Emi M; Tanabe K; Uchida Y; Toge T
    Cancer; 2004 Jun; 100(11):2281-91. PubMed ID: 15160330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer.
    Pu N; Zhao G; Yin H; Li JA; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W
    J Transl Med; 2018 Oct; 16(1):294. PubMed ID: 30359281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MnTE-2-PyP Treatment, or NOX4 Inhibition, Protects against Radiation-Induced Damage in Mouse Primary Prostate Fibroblasts by Inhibiting the TGF-Beta 1 Signaling Pathway.
    Chatterjee A; Kosmacek EA; Oberley-Deegan RE
    Radiat Res; 2017 Mar; 187(3):367-381. PubMed ID: 28225655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming Growth Factor β is a Poor Prognostic Factor and Inhibits the Favorable Prognostic Value of CD8+ CTL in Human Hepatocellular Carcinoma.
    Huang CY; Wang H; Liao W; Han F; Li YQ; Chen SW; Lao XM
    J Immunother; 2017 Jun; 40(5):175-186. PubMed ID: 28394813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta and the immune response to malignant disease.
    Teicher BA
    Clin Cancer Res; 2007 Nov; 13(21):6247-51. PubMed ID: 17975134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.